España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
10x Genomics
TXG
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$10.90
-0.66
-5.71%
At close: -
$10.98
0.08
0.73%
After Hours: 7:52 PM EDT
Get Report
Comment
10x Genomics (TXG) Forecast
News
Earnings
10x Genomics (TXG) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for 10x Genomics (NASDAQ:TXG) Stock
10x Genomics Stock (NASDAQ: TXG)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, February 14, 2025
Morgan Stanley Maintains Overweight on 10x Ge...
Benzinga Newsdesk
Barclays Maintains Overweight on 10x Genomics...
Benzinga Newsdesk
Thursday, February 13, 2025
Canaccord Genuity Maintains Buy on 10x Genomi...
Benzinga Newsdesk
Life Science Company 10x Genomics Struggles With Profitability, Analyst Says 2025 Guidance Bakes In NIH Funding Uncertainties
Vandana Singh
Citigroup Maintains Buy on 10x Genomics, Lowe...
Benzinga Newsdesk
JP Morgan Maintains Neutral on 10x Genomics, ...
Benzinga Newsdesk
UBS Maintains Neutral on 10x Genomics, Lowers...
Benzinga Newsdesk
Stifel Maintains Buy on 10x Genomics, Lowers ...
Benzinga Newsdesk
MGM Resorts To Rally Around 75%? Here Are 10 Top Analyst Forecasts For Thursday
Avi Kapoor
10x Genomics shares are trading lower after L...
Benzinga Newsdesk
Leerink Partners Downgrades 10x Genomics to M...
Benzinga Newsdesk
Wednesday, February 12, 2025
10x Genomics Sees FY2025 Sales $610.000M-$630...
Benzinga Newsdesk
10x Genomics Q4 EPS $(0.40) Misses $(0.30) Es...
Benzinga Newsdesk
Earnings Scheduled For February 12, 2025
Benzinga Insights
Monday, February 10, 2025
10x Genomics shares are trading lower after B...
Benzinga Newsdesk
Barclays Maintains Overweight on 10x Genomics...
Benzinga Newsdesk
Saturday, February 08, 2025
Cathie Wood's Ark Invest Bets Big On Amazon, Roblox And Illumina While Trimming Palantir Stake After Alex Karp-Led Company Touched An All-Time High On Thursday
Rounak Jain
Thursday, February 06, 2025
Chan Zuckerberg Initiative Announces Billion ...
Benzinga Newsdesk
Saturday, February 01, 2025
Cathie Wood's Ark Invest Bets On Biotech With CRISPR Therapeutics Investment, Exits Roblox
Rounak Jain
Friday, January 31, 2025
Cathie Wood's Ark Invest Dumps Over $10 Million Worth Of Palantir Stock As AI Competition Heats Up
Shivdeep Dhaliwal
Wednesday, January 15, 2025
The Analyst Verdict: 10x Genomics In The Eyes Of 6 Experts
Benzinga Insights
Monday, January 13, 2025
Morgan Stanley Maintains Overweight on 10x Ge...
Benzinga Newsdesk
Reported Sunday, 10x Genomics Reports $610.8M...
Benzinga Newsdesk
Monday, December 23, 2024
Reported Earlier, Delaware Jury Awards 10x Ge...
Benzinga Newsdesk
Thursday, November 14, 2024
Ray Dalio's Bridgewater Cuts Stake In Microsoft Stock By 20% – Is Big Tech Losing Its Shine?
Surbhi Jain
Friday, November 01, 2024
Barclays Maintains Overweight on 10x Genomics...
Benzinga Newsdesk
Thursday, October 31, 2024
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
Chris Katje
TechBio Startup Cure51 Selects 10x Genomics V...
Benzinga Newsdesk
Wednesday, October 30, 2024
These Analysts Boost Their Forecasts On 10x Genomics After Q3 Results
Avi Kapoor
Citigroup Maintains Buy on 10x Genomics, Lowe...
Benzinga Newsdesk
Goldman Sachs Maintains Sell on 10x Genomics,...
Benzinga Newsdesk
JP Morgan Maintains Neutral on 10x Genomics, ...
Benzinga Newsdesk
UBS Maintains Neutral on 10x Genomics, Lowers...
Benzinga Newsdesk
10x Genomics shares are trading lower after t...
Benzinga Newsdesk
Tuesday, October 29, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
10x Genomics Cuts FY24 Revenue Guidance From ...
Benzinga Newsdesk
10x Genomics Q3 2024 GAAP EPS $(0.30) Beats $...
Benzinga Newsdesk
Tuesday, October 22, 2024
PacBio Onso Short Read Sequencing Instrument ...
Benzinga Newsdesk
Thursday, October 17, 2024
Looking Into 10x Genomics's Recent Short Interest
Benzinga Insights
European Unified Patent Court Rules In Favor ...
Benzinga Newsdesk
Tuesday, October 15, 2024
10x Genomics Delivers 'Single Cell For A Sing...
Benzinga Newsdesk
Thursday, October 10, 2024
S&P Moves Lower; Domino's Pizza Posts Mixed Q3 Results
Avi Kapoor
Where 10x Genomics Stands With Analysts
Benzinga Insights
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Crude Oil Surges 3%; Delta Air Lines Posts Downbeat Earnings
Avi Kapoor
Stephens & Co. Reiterates Overweight on 10x G...
Benzinga Newsdesk
Canaccord Genuity Maintains Buy on 10x Genomi...
Benzinga Newsdesk
Dow Falls Over 100 Points; US Inflation Rate Slows To 2.4% In September
Avi Kapoor
Market-Moving News for October 10th
Benzinga Newsdesk
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch